Search AI Products and News

Recently, a research team from Stanford University conducted an interesting experiment exploring the role of artificial intelligence (AI) in medical diagnosis. They found that when AI transforms from a simple tool into a doctor's partner, the doctors' diagnostic accuracy improves by 10%. The study involved 70 licensed U.S. doctors, aiming to compare the effectiveness of AI with traditional diagnostic methods. Image source note: The image is generated by AI, and the image authorization service provider is Midjourney. In the experiment, doctors and AI jointly analyzed cases, with AI generating...

Hangzhou-based medical AI company, MeiYin Intelligence Technology Co., Ltd., recently announced it has secured millions of yuan in seed funding. The funding will primarily be used for R&D and commercialization of its core product. The round was led by Zhuoyuan Asia, with participation from Xihu Government Direct Investment Fund. MeiYin Intelligence focuses on leveraging AI to predict disease risk and promote health management. Its core product, based on its self-developed DP-LLM large model, supports the processing of multimodal medical data to accurately quantify an individual's future disease risk, covering hundreds of diseases and more.

Alibaba's AI model, DAMO PANDA, has recently received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This achievement marks a significant breakthrough in early pancreatic cancer screening, offering new possibilities for early diagnosis. DAMO PANDA, developed by Alibaba's DAMO Academy, is an AI model focused on pancreatic cancer screening. Its primary function is to analyze plain CT images and accurately identify subtle lesions that are difficult for the human eye to detect.

The health tech sector has seen significant funding recently, highlighting the rapid rise and widespread adoption of artificial intelligence in healthcare. Early-stage venture capital firm SignalFire secured $1 billion in funding to support AI-focused startups. This brings SignalFire's total assets under management to $3 billion, underscoring its prominence in the industry. SignalFire's portfolio includes several healthcare startups, such as Grow.

Alibaba's AI model, DAMO PANDA, has been officially designated a breakthrough medical device by the U.S. Food and Drug Administration (FDA). This certification marks a significant breakthrough for Alibaba in the field of AI-powered healthcare and represents the first time a leading Chinese tech company has received this prestigious recognition. DAMO PANDA, developed by Alibaba's DAMO Academy, is an AI model designed for pancreatic cancer screening. It aims to accurately identify subtle lesions in CT images, aiding in early detection of the disease.

In the field of multimodal artificial intelligence (AI), engineers from Apple have collaborated with a research team from Sorbonne University in France on a significant study. Recently, tech media outlet marktechpost published a blog post discussing the application and prospects of early and late fusion models in multimodal AI. The research indicates that early fusion models trained from scratch offer superior computational efficiency and scalability. Multimodal AI aims to process multiple data types simultaneously, such as images and text; however, integrating these diverse sources presents challenges.

China recently announced a 60 billion RMB (approximately $82 billion USD) national fund dedicated to investing in early-stage artificial intelligence (AI) projects. This move demonstrates Beijing's commitment to fostering the AI industry and aims to further elevate China's position in the global technology competition through government-led investment. According to Zhang Jianhua, an official from the Ministry of Industry and Information Technology, speaking at a conference in Shenzhen, the "National AI Investment Fund" was established in January this year under the joint guidance of industrial and financial departments. The fund's...

In the continuous advancement of medical technology, United Imaging officially launched its latest Yuanzhi medical large model on April 9th. The launch of this large model not only brings new opportunities to the medical industry but also provides doctors and patients with more intelligent services. United Imaging's Yuanzhi large model integrates tens of millions of medical imaging data and hundreds of thousands of precisely annotated data, aiming to improve the efficiency and accuracy of image diagnosis. The Yuanzhi medical large model supports more than 10 imaging modalities and can handle 300 types of image processing tasks. This means it can...

A medical team at Ningbo University Affiliated People's Hospital recently used artificial intelligence to successfully detect early-stage pancreatic cancer in a seemingly routine case. 65-year-old Mr. Qiu visited the hospital due to dizziness for three consecutive days. While routine examinations revealed no abnormalities, the AI system, through in-depth analysis of his imaging data, issued a timely alert indicating a potential risk of pancreatic cancer. This case utilized a "Plain CT Scan + AI" approach, a cutting-edge technology that...

Glaucoma, the 'silent thief of sight,' threatens the vision of 26 million people in China. But now, a breakthrough has arrived. 'Xiao Qing,' a powerful AI tool, has been launched in collaboration with leading Chinese medical institutions to combat glaucoma and restore hope for patients. Recently, a 'Glaucoma Chronic Disease Management Center' was launched in Shanghai, a joint initiative of 12 top-tier hospitals including Fudan University Affiliated Eye, Ear, Nose, and Throat Hospital, Sun Yat-sen University Zhongshan Ophthalmic Center, and Beijing Tongren Hospital.

Fudan University Affiliated Zhongshan Hospital and the Shanghai Institute for Advanced Study of Science jointly released CardioMind, China's first cardiovascular AI model. This innovative technology marks a new era of intelligent cardiovascular diagnosis and treatment. Referred to as an "AI cardiologist," the model aims to mimic the thinking patterns of top experts to improve efficiency in cardiovascular disease diagnosis and treatment. Academician Ge Junbo, director of cardiology, noted at the launch that CardioMind is more than just inputting data into AI.